scholarly journals Breast Cancer-Related Lymphedema: Recent Updates on Diagnosis, Severity and Available Treatments

2021 ◽  
Vol 11 (5) ◽  
pp. 402
Author(s):  
Marco Pappalardo ◽  
Marta Starnoni ◽  
Gianluca Franceschini ◽  
Alessio Baccarani ◽  
Giorgio De Santis

Breast cancer-related lymphedema (BCRL) represents a global healthcare issue affecting the emotional and life quality of breast cancer survivors significantly. The clinical presentation is characterized by swelling of the affected upper limb, that may be accompanied by atrophic skin findings, pain and recurrent cellulitis. Cardinal principles of lymphedema management are the use of complex decongestive therapy and patient education. Recently, new microsurgery procedures have been reported with interesting results, bringing in a new opportunity to care postmastectomy lymphedema. However, many aspects of the disease are still debated in the medical community, including clinical examination, imaging techniques, patient selection and proper treatment. Here we will review these aspects and the current literature.

2014 ◽  
Vol 114 (4) ◽  
pp. 239-244 ◽  
Author(s):  
T. R. Lopez Penha ◽  
J. van Bodegraven ◽  
B. Winkens ◽  
E. M. Heuts ◽  
A. C. Voogdi ◽  
...  

2021 ◽  
pp. 026921552110310
Author(s):  
Patricia Martínez-Miranda ◽  
Maria Jesús Casuso-Holgado ◽  
José Jesús Jiménez-Rejano

Objective: To synthesise the existing evidence about the effect of patient education, either used alone or as adjunctive therapy, on the improvement of quality of life, pain and fatigue in adult breast cancer survivors. Data sources: We searched PubMed, Web of Science, CINAHL, SCOPUS, Cochrane Plus, PEDro, Dialnet and Clinicaltrials.gov databases. Methods: We conducted this systematic review in accordance with the PRISMA statement. Only randomised controlled trials with adult breast cancer survivors were included. We assessed the methodological quality of the studies using the PEDro scale and the Cochrane risk-of-bias tool. We synthesised evidence using the GRADE tool. Results: We included 14 studies (PEDro 4–8 points) comprising 1749 adult women who survived breast cancer, of which we included 12 in the quantitative analysis. There were statistically significant short-term benefits for improved global quality-of-life (standardised mean difference [SMD] = 0.43, P = 0.05, 95% CI [0.00, 0.85]; GRADE: low certainty; not important), emotional quality-of-life (SMD = 0.32, P = 0.04, 95% CI [0.02, 0.62]) and fatigue (SMD = 0.24, P = 0.0004, 95% CI [0.11, 0.37]; GRADE: low certainty; not important). However, there were not statistically significant for pain severity (SMD = −0.05, P = 0.67, 95% CI [−0.26, 0.17]; GRADE: low certainty; not important) and fear to recurrence (SMD = −0.05, P = 0.68, 95% CI [−0.31, 0.20]; GRADE: moderate certainty; not important). Conclusion: Patient education have a significative effect in short-term global quality-of-life, emotional quality-of-life and fatigue, though all the results were classified as ‘not important’.


2015 ◽  
Vol 3 (1) ◽  
pp. 38 ◽  
Author(s):  
Awad Alawad ◽  
Ayat Omer Ibrahim

<p><strong>Background:</strong> Lymphedema is a highly prevalent condition in women who have undergone treatment for breast cancer. Lymphedema negatively affects the quality of life.</p><p><strong>Objective:</strong> The aim of this study was to identify the clinical presentation of lymphedema associated factors in women treated for breast cancer.</p><p><strong>Methods:</strong>The study is an interventional prospective study. It was accomplished in the period from May 2013 to April 2014. Patients having breast cancer ipsilateral arm lymphedema were selected for the study.</p><p><strong>Results:</strong> A total of 34 patients were included in the study.73.5% of patients have a body mass index (BMI) of 25 or more at diagnosis. 70.6% of the patients underwent axillary clearance. All the patients did not undergo breast reconstruction. 52.4% had &lt;10 lymph nodes removed from their axillae. 47% received radiotherapy. All patients presented with arm swelling, additionally, 70.6 % presented with arm heaviness 26.5% presented with arm pain. Elevation was effective in 90.5% of the compliant patients, while exercise was effective in 84.2% of the compliant patients.</p><p><strong>Conclusion:</strong> Breast cancer- related lymphedema continues to be a significant problem following breast cancer therapy. Presence of co-morbid conditions axillary radiation significantly increases the risk of lymphedema. A combination of axillary dissection axillary radiation should be avoided whenever feasible to avoid lymphedema.</p>


2017 ◽  
Author(s):  
K Thöne ◽  
N Obi ◽  
A Jung ◽  
M Schmidt ◽  
J Chang-Claude ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document